OXYCODONE KAPSLER - AN OVERVIEW

The concomitant utilization of oxycodone HCl with all cytochrome P450 3A4 inhibitors may perhaps cause a rise in oxycodone plasma concentrations, which could increase or prolong adverse reactions and will result in potentially fatal respiratory depression. Moreover, discontinuation of a concomitantly utilised cytochrome P450 3A4 inducer may perhaps